ABOUT PROMENTIS
Management
Board of Directors
Scientific Advisory Board & Founders
TECHNOLOGY
SXC-2023
TRICHOTILLOMANIA
INVESTORS
NEWS & RESOURCES
Press Releases
In the News
Publications, Presentations & Events
CONTACT
✕
EVENTS
Events
Coming Soon!
PRESS RELEASES
Promentis Pharmaceuticals to Present at the 11th Anniversary CNS Summit
Promentis Pharmaceuticals to Present at the 10th Anniversary CNS Summit
Promentis Pharmaceuticals Announces Positive Results for Phase 2A Study of SXC-2023 Targeting Novel Glutamatergic Mechanism and Completion of Enrollment for Phase 2 Trichotillomania Study
Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism